This is a non-competitive combined synopsis/solicitation for commercial items. The National Institutes of Health intends to award a firm-fixed-price contract to Oxford StemTech Ltd in Oxford, UK. The contract covers scientific support services for quality control of Induced Pluripotent Stem Cells and the generation of organoids. The acquisition is conducted under the simplified acquisition threshold.